# Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

> **NCT00332826** · PHASE3 · TERMINATED · sponsor: **Mannkind Corporation** · enrollment: 3 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Asthma

## Interventions

- **DRUG:** Technosphere Insulin

## Key facts

- **NCT ID:** NCT00332826
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Non-safety related business decision to combine special population protocols
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332826, "Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00332826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*